We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -38.00 | -0.32% | 11,988.00 | 12,014.00 | 12,018.00 | 12,144.00 | 11,882.00 | 12,070.00 | 2,340,813 | 16:35:09 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 31.28 | 186.27B |
From Apr 2022 to Apr 2024
By Kathryn Hardison
International stocks trading in New York closed mostly lower on Monday.
The S&P/BNY Mellon index of American depositary receipts fell 0.2% to 135.22. The European index decreased 0.2% to 131.43, the Asian index fell 0.2% to 152.90, the Latin American index rose 0.5% to 188.64 and the emerging markets index decreased 0.1% to 260.85.
Infineon Technologies AG and Roche Holding AG were among the companies with ADRs that traded actively.
ADRs of Infineon Technologies rose 5% after the chipmaker said Monday that it had signed a nonbinding agreement with car maker Stellantis NV on the supply of semiconductors for electric vehicles. This marks the first step toward a potential multi-year supply of silicon-carbide chips, Infineon said, which are widely used in the industrial and automotive industries.
ADRs of Roche Holding fell 4.6% after the company said that phase three graduate studies of gantenerumab, for treatment of early Alzheimer's disease, failed to meet its primary endpoints.
ADRs of AstraZeneca PLC rose 1.8% after the company said Enhertu has been recommended for approval in the European Union for patients with gastric cancer.
Write to Kathryn Hardison at kathryn.hardison@wsj.com
(END) Dow Jones Newswires
November 14, 2022 18:09 ET (23:09 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Astrazeneca Chart |
1 Month Astrazeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
